☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
narcolepsy
Jazz' Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy
November 19, 2021
Harmony Acquires ConSynance's Asset for the Treatment of Narcolepsy and other Rare Neurological Diseases
August 10, 2021
Jazz Reports Results of Xywav (calcium- magnesium- potassium- and sodium oxybates) in P-III Study for Cataplexy or EDS in Patients...
October 21, 2020
Jazz Pharmaceuticals' Xywav (calcium- magnesium- potassium- and sodium oxybates) Receives the US FDA's Approval for Cataplexy or E...
July 22, 2020
Jazz Reports Results of JZP-258 in a P-III Study to Treat Cataplexy and Excessive Daytime Sleepiness in Patients with Narcolepsy
September 26, 2019
Harmony Biosciences' Wakix (pitolisant) Receives the US FDA's Approval for Treatment of Excessive Daytime Sleepiness in Adult Pati...
August 15, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.